Pharmaceutical composition comprising diamorphine for intranasal administration
US-2015231130-A1 · Aug 20, 2015 · US
US11097073B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11097073-B2 |
| Application number | US-201816193696-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 16, 2018 |
| Priority date | May 17, 2016 |
| Publication date | Aug 24, 2021 |
| Grant date | Aug 24, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A nose-to-brain drug delivery device is provided. The nose-to-brain drug delivery device includes a freeze-dried drug container for storing a freeze-dried drug, a restoring solvent container for storing a solvent for thawing the freeze-dried drug, a membrane for preventing the freeze-dried drug from being mixed with the solvent, and a compressor for providing a driving force. The membrane is opened by the driving force of the compressor to mix the freeze-dried drug with the solvent, thereby thawing the freeze-dried drug, and the thawed drug is sprayed by the driving force of the compressor.
Opening claim text (preview).
What is claimed is: 1. A nose-to-brain drug delivery device comprising: a freeze-dried drug container for storing a freeze-dried drug; a restoring solvent container for storing a solvent for reconstituting the freeze-dried drug; a membrane for preventing the freeze-dried drug from being mixed with the solvent; and a compressor for providing a driving force, wherein the membrane is opened by the driving force of the compressor to mix the freeze-dried drug with the solvent, thereby reconstituting the freeze-dried drug, and the reconstituted drug is capable of being sprayed by the driving force of the compressor, wherein the reconstituted drug is capable of being sprayed into a nose of a subject in a mecca position state where a head of the subject faces a chest of the subject, wherein a propellant movement path is provided between the compressor and the restoring solvent container and provides a flow path for compressed gas stored in the compressor, wherein the restoring solvent container is formed of a flexible material and is deformed by the driving force to increase an internal pressure of the restoring solvent container, and the membrane is capable of being opened by the increased internal pressure, wherein one end of the restoring solvent container includes a receiving recess in which one end of the propellant movement path is inserted, and wherein the compressed gas released from the one end of the propellant movement path into the receiving recess is capable of pushing the one end of the restoring solvent container in at least two directions. 2. The nose-to-brain drug delivery device of claim 1 , wherein the compressor provides the driving force to the one end of the restoring solvent container, and another end of the restoring solvent container is blocked by the membrane so as to be separated from the freeze-dried drug container. 3. The nose-to-brain drug delivery device of claim 1 , wherein the freeze-dried drug container includes a fine hole for spraying the reconstituted drug. 4. The nose-to-brain drug delivery device of claim 3 , further comprising: a spray unit, wherein the drug released from the fine hole is capable of being sprayed outward through the spray unit. 5. The nose-to-brain drug delivery device of claim 1 , wherein the restoring solvent container, the membrane, and the freeze-dried drug container are disposed in the order named, from the compressor. 6. The nose-to-brain drug delivery device of claim 1 , further comprising: a first housing in which the compressor is received; and a second housing in which the restoring solvent container, the membrane, and the freeze-dried drug container are received, wherein the second housing is detachable from the first housing, and a longitudinal direction of the first housing forms an acute angle with a longitudinal direction of the second housing when the first housing is coupled to the second housing. 7. The nose-to-brain drug delivery device of claim 1 , wherein a spray pressure of the reconstituted drug ranges from 6 psi to 20 psi. 8. The nose-to-brain drug delivery device of claim 7 , wherein the spray pressure of the reconstituted drug ranges from 6 psi to 15 psi.
by squeezing, e.g. using a flexible bottle or a bulb · CPC title
by bursting or breaking the package, i.e. without cutting or piercing · CPC title
Brain, cerebrum · CPC title
Syringe-type or piston-type sprayers or atomisers · CPC title
using capsules, e.g. to be perforated or broken-up · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.